ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 56 for:    Inclusion Body Myositis

Study of Arimoclomol in Inclusion Body Myositis (IBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02753530
Recruitment Status : Recruiting
First Posted : April 28, 2016
Last Update Posted : October 12, 2018
Sponsor:
Collaborators:
University of Kansas Medical Center
University College, London
Information provided by (Responsible Party):
Orphazyme

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : December 2021